BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8603347)

  • 1. Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemia.
    Lim SW; Falk RE; Look RM; Fuerst MM; Lawrence GN; Kusuanco DA; Giles FJ
    Cancer Genet Cytogenet; 1996 Feb; 86(2):165-7. PubMed ID: 8603347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked bone marrow eosinophilia at the time of relapse of acute myeloblastic leukaemia in association with the appearance of translocation t(12;20)(q24;q11).
    Partridge F; Richardson W; Kearns P; Wilcox R; Majumdar G
    Leuk Lymphoma; 1996 Jun; 22(1-2):181-2. PubMed ID: 8724547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia.
    Shi G; Weh HJ; Hossfeld DK
    Cancer Genet Cytogenet; 1993 Oct; 70(2):140-1. PubMed ID: 8242596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
    Brown SA; Czepulkowski B; Ireland R
    Leuk Res; 1996; 20(11-12):987-8. PubMed ID: 9009258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of program acute myeloid leukemia therapy use in National Medical Research Center for Hematology of the Ministry of Health of Russian Federation.
    Parovichnikova EN; Loukianova IA; Troitskaya VV; Drokov MY; Lobaova TI; Kuzmina LA; Sokolov AN; Kokhno AV; Fidarova ZT; Baskhaeva GA; Gavrilina OA; Vasilyeva VA; Obukhova TN; Kuznetsova SA; Sudarikov AB; Dvirnik VN; Galtseva IV; Davidiva JO; Kulikov SM; Savchenko VG
    Ter Arkh; 2018 Aug; 90(7):14-22. PubMed ID: 30701918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unfavourable outcome of a patient with M2 acute non lymphocytic leukemia and a 47,XY,t(5;7)(q34;q21), +8 karyotype.
    Testoni N; Zaccaria A; Celso B; Tura S
    Haematologica; 1991; 76(1):65-8. PubMed ID: 2055562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel translocation (2;4) with consistent involvement of 2p23 in acute nonlymphocytic leukemia (M2).
    Farag S; Challis J; White J; Garson OM
    Cancer Genet Cytogenet; 1992 Jan; 58(1):48-51. PubMed ID: 1728949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).
    Corral Mdel P; Villa O; Alfaro EM; Alonso CN; Baro C; Felice MS; Rossi J; Solé F; Gallego MS
    Pediatr Blood Cancer; 2008 Mar; 50(3):651-4. PubMed ID: 17405156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia.
    Liu H; Fu R; Li L; Wang G; Song J; Ruan E; Wang H; Wu Y; Wang X; Ding K; Shao Z
    Clin Drug Investig; 2017 Feb; 37(2):167-174. PubMed ID: 27722823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
    Fujisawa S; Togawa J; Tanaka M; Koharazawa H; Aoba M; Fujita H; Murata T; Kanamori H; Matsuzaki M; Mohri H; Ishigatsubo Y
    Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
    Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
    Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression.
    Shi P; Zha J; Guo X; Chen F; Fan Z; Huang F; Meng F; Liu X; Feng R; Xu B
    Pharmacogenomics; 2013 Jan; 14(1):17-23. PubMed ID: 23252945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation (2;3)(p13;q26) in two cases of myeloid malignancies. Acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia.
    Fleischman EW; Volkova MA; Frenkel MA; Konstantinova LN; Kulagina OE; Baranov AE; Gordeeva AA
    Cancer Genet Cytogenet; 1996 Apr; 87(2):182-4. PubMed ID: 8625269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloblastic leukemia (M0) with an unusual chromosomal abnormality: translocation (1;14)(p13;q32).
    Tecimer C; Loy BA; Martin AW
    Cancer Genet Cytogenet; 1999 Jun; 111(2):175-7. PubMed ID: 10347560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature.
    Zhang XH; Zhang R; Li Y
    Leuk Res; 2010 Jul; 34(7):958-61. PubMed ID: 20116851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome of acute myelogenous leukemia in 41 patients treated with idarubicin: the prognosis of t(8;21) cases].
    Matsumoto Y; Mori M; Ohtsuki T; Muroi K; Hatake K; Komatsu N; Ozawa K
    Rinsho Ketsueki; 2001 Jan; 42(1):15-22. PubMed ID: 11235129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia with a severe coagulopathy and t(8;16)(p11;p13).
    Hastings A; Apperley JF; Nadal-Melsio E; Brown L; Bain BJ
    Am J Hematol; 2021 Jan; 96(1):163-164. PubMed ID: 32520413
    [No Abstract]   [Full Text] [Related]  

  • 18. Two additional cases of acute myeloid leukemia with t(7;11)(p15;p15) having low neutrophil alkaline phosphatase scores.
    Fujimura T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Iwabuchi A; Kodama A; Toyama K
    Cancer Genet Cytogenet; 1993 Jul; 68(2):143-6. PubMed ID: 8353806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicators.
    Giles FJ; Kanemaki TJ; Schreck RR; Qasabian L; Fuerst MP; Lim SW
    Cancer Genet Cytogenet; 1998 Jul; 104(1):66-9. PubMed ID: 9648562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.